Showing 24 of 24 results

Edson Utazi, Dan Hogan
Communities at risk of non- and under-vaccination are often characterized by poverty, lack of access to health care and other basic services, civil/political unrest, poor sanitation practices,...
World Health Organization (WHO)
The purpose of this guide is to describe the recommended process for assessing and validating MNT elimination in countries believed to have achieved that goal.
S. Desai, Heather M. Scobie, Thomas Cherian, Tracey Goodman
Td (reduced diphtheria toxoid, ≥2–5 IU) vaccines are currently licensed for ages 7 years and older, but use of Td vaccine for ages 4 years and older would have advantages for immunization...
World Health Organization (WHO), UNICEF
You will find here 3 documents: 1- WHO/UNICEF Joint Communique – Replacement of TT with Td vaccine for dual protection 2- WHO/UNICEF GUIDANCE NOTE Ensuring Sustained Protection Against...
World Health Organization (WHO)
This annex provides guidance on the use of serosurveys to estimate population immunity and monitor disease risk for tetanus. The aims of tetanus vaccination are 1) to achieve and sustain maternal and...
Dietz V, Milstien JB, van Loon F, Cochi S, Bennett J
Neonatal tetanus (NT) is a major cause of mortality in developing countries, with over 400,000 deaths estimated to occur annually. WHO has adopted the goal of eliminating NT worldwide, and a major...
Cochi S, van Loon F, Galazka A, Dietz V
An estimated 400,000 deaths occur annually from neonatal tetanus (NT). In 1989 WHO adopted the goal of eliminating NT as a public health problem worldwide. To achieve this, and to control...
Keith P Klugman, Sharon Bergquist, Ajoke Sobanjo-ter Meulen
Although considerable progress has been made globally to reduce under-5 mortality, advances in the reduction of neonatal deaths in the first year of life have been slower. The annual deaths of almost...
David L. Day, Sandra Melendez, Mary Powell, Glenda Bastin, Robert Brawley, Margaret Jones, Julie Miracle, Nancy Allen, Anna Q. Yaffee
On July 11, 2016, state and local health departments in Kentucky were notified of a case of obstetric tetanus in an unvaccinated woman. Obstetric tetanus, which occurs during pregnancy or within 6...
Richard W. Compans, Mark R. Prausnitz, Joshy Jacob, Ioanna Skountzou, Elena V. Vassilieva, E. Stein Esser, Andrey A. Romanyuk
Maternal and neonatal tetanus claim tens of thousands lives every year in developing countries, but could be prevented by hygienic practices and improved immunization of pregnant women. This study...
S. Collins et al.
Public Health England conducts enhanced national surveillance of tetanus, a potentially life-threatening vaccine-preventable disease. A standardized questionnaire was used to ascertain clinical and...
UNICEF
A mere $1.20 prevents the death of a mother and her future babies from tetanus. Yet 180,000 infants and 30,000 women still die each year from the disease, easily preventible through immunization and...
World Health Organization (WHO)
Tetanus is an acute, potentially fatal disease caused by a neurotoxin produced by the bacterium Clostridium tetani. Maternal and neonatal tetanus (MNT) are forms of generalized tetanus affecting...
World Health Organization (WHO)
Indonesia has a long-standing history and commitment to MNTE though vaccination and safe motherhood strategies. The country made efforts to eliminate NT through routine TTCV immunization of pregnant...
Caroline Eubelen et al.
General practitioners (GPs) often lack time and resources to invest in health education; audiovisual messages broadcast in the waiting room may be a useful educational tool. This work was designed to...
Onder Ergonul et al.
1 million cases of tetanus are estimated to occur worldwide each year, with more than 200 000 deaths. Tetanus is a life-threatening but preventable disease caused by a toxin produced by Clostridium...
Adeel Ahmed Khan, Aysha Zahidie, Fauziah Rabbani
In 1988, WHO estimated around 787,000 newborns deaths due to neonatal tetanus. Despite few success stories majority of the Low and Middle Income Countries (LMICs) are still struggling to reduce...
C Louise Thwaites et al.
Maternal and neonatal tetanus is still a substantial but preventable cause of mortality in many developing countries. Case fatality from these diseases remains high and treatment is limited by...
Vittorio Demicheli et al.
Two trials (10,560 infants) were included. One study (1919 infants) assessed the effectiveness of tetanus toxoid in preventing neonatal tetanus deaths. After a single dose, the relative risk (RR) was...
Alison M. Elliott
Some vaccines show poor efficacy in tropical countries. Within a birth cohort in Uganda, we investigated factors that might influence responses to BCG and tetanus immunisation. Whole blood assay...
Bruce Y. Lee et al.
Making any EPI vaccine thermostable relieved existing supply chain bottlenecks (especially at the lowest levels), increased vaccine availability of all EPI vaccines, and decreased cold storage and...
Raza SA and Avan BI
In the context of resource-poor settings in low-income countries with poor coverage of tetanus toxoid immunization, the use of CDKs seems to be an effective strategy for reducing NNT infection,...
Simona Zipursky, Primitive Gakima, Paul Baoundoh, Mbaihol Tamadji, Martha H. Roper, Florence Fermon, Céline Langendorf, Camille Domicent, Aitana Juan-Giner, Rebecca F. Grais
Background: In resource-poor settings, cold chain requirements present barriers for vaccine delivery. We evaluated the immunogenicity and safety of tetanus toxoid (TT) vaccine in “Controlled...
Rosser- W W, Hutchison- B G, McDowell- I & Newell- C
OBJECTIVE: To assess the effect of three computerized reminder systems on compliance with tetanus vaccination. DESIGN: Prospective randomized controlled trial. SETTING: Ottawa Civic Hospital Family...